Cincinnati, OHNCT05027906Now EnrollingIRB Ready

Prevention of Rejection in Kidney Transplant Clinical Trial in Cincinnati, OH

Access cutting-edge prevention of rejection in kidney transplant treatment through this phase 1/2 clinical trial at a research site in Cincinnati. Study-provided care at no cost to qualified participants.

Sponsored by Eledon Pharmaceuticals

Quick Self-Assessment

See if you qualify for this Cincinnati location

Preparing your pre-screening questions…

Expert Care in Cincinnati

Access prevention of rejection in kidney transplant specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related prevention of rejection in kidney transplant treatment provided free

Apply for This Cincinnati Location

Check if you qualify for this prevention of rejection in kidney transplant clinical trial in Cincinnati, OH

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Cincinnati

    Convenient for OH residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Cincinnati site if eligible
  4. 4Begin participation

About This Prevention of Rejection in Kidney Transplant Study in Cincinnati

This study will evaluate the safety, PK, and efficacy of AT 1501 in patients undergoing kidney transplantation.

Sponsor: Eledon Pharmaceuticals

Who Can Participate

Inclusion Criteria

Male or female ≥ 18 years of age
Recipient of their first kidney transplant from a living or deceased donor
Agree to comply with contraception requirements during and for at least 90 days after the last administration of study drug

Exclusion Criteria

Induction therapy, other than study assigned rATG, planned as part of initial immunosuppressive regimen
Currently treated with any systemic immunosuppressive regimen, including immunologic biologic therapies, with the exception of 5 mg prednisone or equivalent daily;
Previous treatment with AT 1501 or any other anti CD40LG therapy
The patient has previously received a bone marrow transplant or any other solid organ transplant, including a kidney, or will be undergoing a multi organ or dual kidney transplant
Will receive a kidney with an anticipated cold ischemia time of \> 30 hours;
Will receive a kidney from a donor that meets any of the following criteria:
Donation after Cardiac Death (DCD) criteria; or
Extended Criteria Donor (ECD) criteria, defined as:
Is blood group (ABO) incompatible; or
Age ≥ 60 years; or Age 50-59 years with any 2 of the following criteria:
Death due to cerebrovascular accident
History of hypertension
Terminal creatinine ≥ 133 μmol/L (1.5 mg/dL)
Human leukocyte antigen identical (two haplotype match or zero HLA mismatch) donor
Medical conditions that require chronic use of systemic steroids at a dose higher than 5 mg prednisone or equivalent per day
History of a TE event, known hypercoagulable state, or condition requiring long term anticoagulation:
Positive T- or B-cell crossmatch that is due to HLA antibodies or presence of a DSA at Screening

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Cincinnati?

Yes, this clinical trial (NCT05027906) has an active research site in Cincinnati, OH that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Prevention of Rejection in Kidney Transplant Treatment Options in Cincinnati, OH

If you're searching for prevention of rejection in kidney transplant treatment options in Cincinnati, OH, this clinical trial (NCT05027906) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Cincinnati research site is actively enrolling participants for this phase 1/2 clinical trial. You'll receive care from experienced prevention of rejection in kidney transplant specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all prevention of rejection in kidney transplant clinical trials near you to find additional studies recruiting in your area.

More Rheumatoid Arthritis Trials in Cincinnati, OH

See all rheumatoid arthritis clinical trials recruiting in Cincinnati — not just this study.

Browse Rheumatoid Arthritis Trials in Cincinnati →

Browse More Trials by Condition

Rheumatoid Arthritis TrialsAll Conditions →

Ready to Join in Cincinnati?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Cincinnati, OH